Health service policy

• Health & Medicine

Advanced ovarian cancer drug gets initial ‘no’ for NHS in England

A targeted drug with potential to slow the progress of ovarian cancer has been rejected for use on the NHS in England. A targeted drug with potential to slow the progress of ovarian cancer has been rejected for use on the NHS in England.

9 August 2019

• Health & Medicine

Lung cancer immunotherapy combo added to Cancer Drugs Fund

Combining an immunotherapy with chemotherapy has been recommended as a treatment for some patients with lung cancer on the NHS in England. Combining an immunotherapy with chemotherapy has been recommended as a treatment for some patients with lung cancer on the NHS in England.

8 August 2019

• Health & Medicine

Daily aspirin reduces bowel cancer risk in people with Lynch syndrome, says NICE

Taking a daily aspirin for more than two years could reduce the risk of bowel cancer in people with Lynch syndrome, according to new draft guidance from NICE. Taking a daily aspirin for more than two years could reduce the risk of bowel cancer in people with Lynch syndrome, according to new draft guidance from NICE.

2 August 2019

• Policy & Insight

Opinion: ‘Building an NHS workforce for the future must be Boris Johnson’s top health priority’

With a new Prime Minister in office, the Government's commitments to supporting the NHS and building on the strength of science in the UK must become reality. With a new Prime Minister in office, the Government's commitments to supporting the NHS and building on the strength of science in the UK must become reality.

31 July 2019

• Health & Medicine

Ovarian cancer drug will be offered earlier to NHS patients in England

A targeted drug for advanced ovarian cancer will be more widely available for certain patients on the NHS in England. A targeted drug for advanced ovarian cancer will be more widely available for certain patients on the NHS in England.

26 July 2019

• Health & Medicine

Second breast cancer treatment combo added to England's Cancer Drugs Fund

Some patients with advanced breast cancer will now have access to a new drug combo on the NHS in England – after the NICE reversed its initial decision Some patients with advanced breast cancer will now have access to a new drug combo on the NHS in England – after the NICE reversed its initial decision

17 July 2019

• Health & Medicine

Three new cancer treatments available for NHS patients in Scotland

A breast cancer drug and two blood cancer treatments have been recommended for use on the NHS in Scotland. A breast cancer drug and two blood cancer treatments have been recommended for use on the NHS in Scotland.

11 July 2019

• Health & Medicine

New skin cancer immunotherapy added to NHS England’s Cancer Drugs Fund

A new immunotherapy treatment for certain advanced skin cancer patients is to be made available on the NHS in England. A new immunotherapy treatment for certain advanced skin cancer patients is to be made available on the NHS in England.

4 July 2019

• Health & Medicine

The first complete picture of how long it takes to diagnose cancer in England

Researchers have gathered the most complete picture of how long people wait for a cancer diagnosis in England. And there's huge variation between referrals. Researchers have gathered the most complete picture of how long people wait for a cancer diagnosis in England. And there's huge variation between referrals.

30 June 2019

• Health & Medicine

NHS to ‘fast track’ new personalised cancer medicines – but it’s not ready quite yet

NHS England announced plans to fast track “revolutionary” new cancer drugs. But there’s still some way to go before these drugs might reach patients. NHS England announced plans to fast track “revolutionary” new cancer drugs. But there’s still some way to go before these drugs might reach patients.

19 June 2019

• Health & Medicine

NICE U-turn opens up new treatment option for some adults with leukaemia

Patients living with a specific type of leukaemia will have access to a new immunotherapy treatment on the NHS in England. Patients living with a specific type of leukaemia will have access to a new immunotherapy treatment on the NHS in England.

19 June 2019

• Health & Medicine

Kidney and lung cancer drugs approved on the NHS in Scotland

One kidney cancer treatment and two lung cancer drugs have been recommended for use on the NHS in Scotland. One kidney cancer treatment and two lung cancer drugs have been recommended for use on the NHS in Scotland.

12 June 2019